- Home
- CLMT vs LENZ Comparison
CLMT vs LENZ Comparison
Compare CLMT & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLMT
- LENZ
- Stock Information
- Founded
- CLMT 1916
- LENZ 2019
- Country
- CLMT United States
- LENZ United States
- Employees
- CLMT N/A
- LENZ N/A
- Industry
- CLMT Oil & Gas Production
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- CLMT Energy
- LENZ Health Care
- Exchange
- CLMT Nasdaq
- LENZ Nasdaq
- Market Cap
- CLMT 1.4B
- LENZ 1.1B
- IPO Year
- CLMT 2006
- LENZ 2021
- Fundamental
- Price
- CLMT $17.34
- LENZ $40.41
- Analyst Decision
- CLMT Strong Buy
- LENZ Strong Buy
- Analyst Count
- CLMT 6
- LENZ 4
- Target Price
- CLMT $20.38
- LENZ $49.75
- AVG Volume (30 Days)
- CLMT 805.3K
- LENZ 507.7K
- Earning Date
- CLMT 11-07-2025
- LENZ 11-05-2025
- Dividend Yield
- CLMT N/A
- LENZ N/A
- EPS Growth
- CLMT N/A
- LENZ N/A
- EPS
- CLMT N/A
- LENZ N/A
- Revenue
- CLMT $4,070,400,000.00
- LENZ $5,000,000.00
- Revenue This Year
- CLMT $1.02
- LENZ N/A
- Revenue Next Year
- CLMT $2.01
- LENZ $258.37
- P/E Ratio
- CLMT N/A
- LENZ N/A
- Revenue Growth
- CLMT N/A
- LENZ N/A
- 52 Week Low
- CLMT $7.68
- LENZ $16.54
- 52 Week High
- CLMT $25.29
- LENZ $42.77
- Technical
- Relative Strength Index (RSI)
- CLMT 60.65
- LENZ 57.68
- Support Level
- CLMT $17.10
- LENZ $39.09
- Resistance Level
- CLMT $17.97
- LENZ $42.66
- Average True Range (ATR)
- CLMT 0.72
- LENZ 1.94
- MACD
- CLMT 0.16
- LENZ -0.08
- Stochastic Oscillator
- CLMT 70.00
- LENZ 61.91
About CLMT Calumet Specialty Products Partners L.P. Common Units
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.